JT

Jonathan Trollip

Spheria Emerging Companies Limited | Non-Executive Chairman, Non-Executive Director
Mr Trollip is a non executive director with several years of commercial, corporate, governance, legal and transaction experience. Prior to becoming a professional non executive director, he worked as a principal of Meridian International Capital Limited, and before that, he was a Partner with law firm Herbert Smith Freehills. In the philanthropy area, he is chairman of the PNI Foundation.

Companies and Roles

Company
Title
Tenure
Since
SEC
SEC
Spheria Emerging Companies Limited
  • Non-Executive Chairman
  • Non-Executive Director
8yrs, 10mthSep 2017
PL8
PL8
Plato Income Maximiser Limited
  • Non-Executive Chairman
  • Non-Executive Director
9yrs, 4mthFeb 2017
GVF
GVF
Staude Capital Global Value Fund Limited
  • Non-Executive Chairman
  • Non-Executive Director
12yrs, 3mthMar 2014
KP2
KP2
Kore Potash Plc
  • Non-Executive Director
8yrs, 8mthNov 2017
BDX
BDX
BCAL Diagnostics Limited
  • Non-Executive Director
5yrs, 6mthDec 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
KP2
KP2
Kore Potash Plc
30/12/257,276,296N/A2,000,000N/A
SEC
SEC
Spheria Emerging Companies Limited
22/08/25N/A77,300N/AN/A
GVF
GVF
Staude Capital Global Value Fund Limited
30/06/25N/A425,000N/AN/A
BDX
BDX
BCAL Diagnostics Limited
30/06/25N/A6,303,4422,000,000N/A
PL8
PL8
Plato Income Maximiser Limited
30/06/25N/A149,299N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
KP2
KP2
Kore Potash Plc
11/06/25
Issued
2,000,000$0.011$21,600Issue of options
BDX
BDX
BCAL Diagnostics Limited
18/12/24
Issued
2,000,000$0.092$184,000Issue of options
BDX
BDX
BCAL Diagnostics Limited
18/12/24
Issued
1,000,000$0.092$92,000Issue of securities
BDX
BDX
BCAL Diagnostics Limited
25/07/24
Issued
500,000$0.100$50,000Placement
BDX
BDX
BCAL Diagnostics Limited
24/11/23
Issued
200,000$0.100$20,000Placement